109 related articles for article (PubMed ID: 30421156)
1. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study.
Arthur R; Møller H; Garmo H; Häggström C; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Van Hemelrijck M
Cancer Causes Control; 2019 Feb; 30(2):195-206. PubMed ID: 30421156
[TBL] [Abstract][Full Text] [Related]
2. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories.
Arthur R; Møller H; Garmo H; Holmberg L; Stattin P; Malmstrom H; Lambe M; Hammar N; Walldius G; Robinson D; Jungner I; Hemelrijck MV
Cancer Med; 2016 Jun; 5(6):1307-18. PubMed ID: 26923095
[TBL] [Abstract][Full Text] [Related]
3. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort.
Bosco C; Garmo H; Hammar N; Walldius G; Jungner I; Malmström H; Holmberg L; Van Hemelrijck M
BMC Cancer; 2018 Feb; 18(1):205. PubMed ID: 29463235
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose.
Van Hemelrijck M; Garmo H; Holmberg L; Walldius G; Jungner I; Hammar N; Lambe M
Cancer; 2011 May; 117(10):2086-95. PubMed ID: 21523720
[TBL] [Abstract][Full Text] [Related]
5. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
[TBL] [Abstract][Full Text] [Related]
6. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.
Melvin JC; Garmo H; Holmberg L; Hammar N; Walldius G; Jungner I; Lambe M; Van Hemelrijck M
BMC Cancer; 2017 Apr; 17(1):246. PubMed ID: 28376727
[TBL] [Abstract][Full Text] [Related]
7. Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality.
Bernardo BM; Orellana RC; Weisband YL; Hammar N; Walldius G; Malmstrom H; Ahlbom A; Feychting M; Schwartzbaum J
Br J Cancer; 2016 Jun; 115(1):108-14. PubMed ID: 27253176
[TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose.
Lindkvist B; Appelros S; Regnér S; Manjer J
Pancreatology; 2012; 12(4):317-24. PubMed ID: 22898632
[TBL] [Abstract][Full Text] [Related]
9. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
[TBL] [Abstract][Full Text] [Related]
10. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study.
Van Hemelrijck M; Walldius G; Jungner I; Hammar N; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L
Cancer Causes Control; 2011 Jul; 22(7):1011-9. PubMed ID: 21562751
[TBL] [Abstract][Full Text] [Related]
11. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
Murtola TJ; Kasurinen TVJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):66-76. PubMed ID: 30214034
[TBL] [Abstract][Full Text] [Related]
12. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study.
Van Hemelrijck M; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Holmberg L
Int J Cancer; 2012 May; 130(9):2118-28. PubMed ID: 21630265
[TBL] [Abstract][Full Text] [Related]
13. Serum inflammatory markers and colorectal cancer risk and survival.
Ghuman S; Van Hemelrijck M; Garmo H; Holmberg L; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Br J Cancer; 2017 May; 116(10):1358-1365. PubMed ID: 28376082
[TBL] [Abstract][Full Text] [Related]
14. Blood lipid levels and prostate cancer risk; a cohort study.
Kok DE; van Roermund JG; Aben KK; den Heijer M; Swinkels DW; Kampman E; Kiemeney LA
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):340-5. PubMed ID: 21727905
[TBL] [Abstract][Full Text] [Related]
15. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study.
Van Hemelrijck M; Hermans R; Michaelsson K; Melvin J; Garmo H; Hammar N; Jungner I; Walldius G; Holmberg L
Cancer Causes Control; 2012 Aug; 23(8):1349-58. PubMed ID: 22710746
[TBL] [Abstract][Full Text] [Related]
16. Prospective study on metabolic factors and risk of prostate cancer.
Häggström C; Stocks T; Ulmert D; Bjørge T; Ulmer H; Hallmans G; Manjer J; Engeland A; Nagel G; Almqvist M; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
Cancer; 2012 Dec; 118(24):6199-206. PubMed ID: 23090855
[TBL] [Abstract][Full Text] [Related]
17. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study.
Melvin JC; Seth D; Holmberg L; Garmo H; Hammar N; Jungner I; Walldius G; Lambe M; Wigertz A; Van Hemelrijck M
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1381-4. PubMed ID: 22593241
[TBL] [Abstract][Full Text] [Related]
18. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T
Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations.
Häggström C; Stocks T; Nagel G; Manjer J; Bjørge T; Hallmans G; Engeland A; Ulmer H; Lindkvist B; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
Epidemiology; 2014 Nov; 25(6):823-8. PubMed ID: 25207955
[TBL] [Abstract][Full Text] [Related]
20. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
